Integrating CRISPR Technology with Key Genetic Markers in Pancreatic Cancer: A New Frontier in Targeted Therapies

Integrating CRISPR Technology with Key Genetic Markers in Pancreatic Cancer: A New Frontier in Targeted Therapies

Pancreatic cancer is the result of mutations in crucial genetic markers like <i>KRAS</i> and <i>TP53</i> that make treatment challenging. This article discusses how CRISPR Cas9 technology can be combined with these markers to create treatments. CRISPR allows for the alteratio...

Full description

Saved in:
Bibliographic Details
Main Author: Dimitrios Stefanoudakis
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:SynBio
Subjects:
CRISPR-Cas9
pancreatic cancer
<i>KRAS</i>
TP53
CDKN2A
SMAD4
Online Access:https://www.mdpi.com/2674-0583/3/1/1
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items